Cytosorbents Corp

CTSO

Cytosorbents Corp

CTSO

Insider Sentiment (TTM):

Last Purchase:2026-06-15Last Sale:-Shares Purchased (TTM):110,333Shares Sold (TTM):0

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:16,456,658Shares Outstanding:62,738,827Institutional Ownership Pct.:26.23%

Earnings Market Reaction:

Filing Date:2026-08-06Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value	4	5	6	8	10	12	3	6	8	9	14	8
Restricted Cash Current	-	2	-	-	-	-	5	-	-	-	-	-
Accounts Receivable Net Current	7	7	8	7	8	8	7	7	8	7	6	6
Inventory Net	4	4	5	4	4	3	3	3	4	4	3	3
Prepaid Expense And Other Assets Current	1	1	2	2	1	3	3	1	1	1	2	2
Assets Current	16	18	21	21	23	25	22	17	22	20	25	19
Property Plant And Equipment Net	7	8	8	8	8	9	9	9	9	10	10	10
Restricted Cash Noncurrent	2	2	2	2	2	2	1	6	6	1	1	2
Operating Lease Right Of Use Asset	11	11	11	11	11	11	12	12	12	12	12	12
Finite Lived Intangible Assets Net	3	3	3	-	-	-	4	-	-	-	-	-
Other Assets Noncurrent	0	0	0	4	4	4	0	4	4	4	4	4
Assets	38	41	44	46	48	51	47	48	53	47	53	48
Liabilities And Stockhold…
Liabilities Current
Accounts Payable Current	2	3	3	3	3	3	3	2	3	2	4	3
Operating Lease Liability Current	1	1	1	1	0	0	0	0	0	0	0	0
Long Term Debt Current	14	7	-	-	-	-	-	-	-	3	3	1
Liabilities Current	24	16	10	10	10	10	10	8	10	13	14	12
Operating Lease Liability Noncurrent	12	12	12	12	12	12	12	13	13	13	13	13
Long Term Debt Noncurrent	3	10	17	15	14	14	14	14	14	2	3	4
Liabilities	39	38	38	37	36	36	36	35	37	28	29	29
Stockholders Equity
Common Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Additional Paid In Capital	322	322	321	320	319	318	311	308	308	306	306	292
Accumulated Other Comprehensive Income Loss Net Of…	-1	-2	-3	-4	-4	2	4	-0	2	2	1	3
Retained Earnings Accumulated Deficit	-322	-317	-312	-307	-304	-305	-304	-295	-293	-289	-283	-277
Stockholders Equity	-1	2	6	9	12	15	11	13	17	20	23	19
Liabilities And Stockholders Equity	38	41	44	46	48	51	47	48	53	47	53	48
Allowance For Doubtful Accounts Receivable Current	0	0	0	0	0	0	0	0	0	0	0	0
Preferred Stock Par Or Stated Value Per Share	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001
Preferred Stock Shares Authorized	5	5	5	5	5	5	5	5	5	5	5	5
Preferred Stock Shares Issued	0	0	0	0	0	0	0	0	0	0	0	0
Preferred Stock Shares Outstanding	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Par Or Stated Value Per Share	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001
Common Stock Shares Authorized	100	100	100	100	100	100	100	100	100	100	100	100
Common Stock Shares Issued	63	63	63	63	63	63	55	55	54	54	54	44
Shares Outstanding	63	63	63	63	63	63	55	55	54	54	54	44

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	-19.61%	-31.70%	-36.78%	-	-	-	-	-	-	-	-	-
2025	31.19%	34.90%	7.55%	5.60%	4.59%	-4.82%	9.61%	-1.50%	-5.41%	12.14%	-17.68%	-21.79%
2024	11.11%	-13.21%	27.16%	15.08%	32.96%	11.73%	7.42%	4.10%	15.17%	10.00%	-15.50%	18.00%
2023	-	-	-	-	-	-	-7.14%	-11.90%	-21.43%	14.77%	0.00%	2.27%
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Liquidity Ratios
Current Ratio	0.66	1.09	2.13	2.11	2.34	2.61	2.20	1.97	2.12	1.49	1.81	1.61
Quick Ratio	0.47	0.73	1.42	1.48	1.82	1.98	1.59	1.46	1.58	1.15	1.44	1.21
Working Capital	-8.29M	1.45M	10.93M	11.20M	13.15M	15.68M	11.78M	8.17M	11.62M	6.57M	11.36M	7.29M
Leverage & Debt
Debt to Equity	-51.55	17.49	6.48	4.07	3.14	2.49	3.27	2.60	2.11	1.43	1.26	1.57
Interest Coverage TTM	-4.15	-4.86	-5.65	-5.53	-6.46	-7.85	-11.76	-28.06	-94.38	-283.24	-202.35	-176.63
Debt Ratio	1.02	0.95	0.87	0.80	0.76	0.71	0.77	0.73	0.69	0.60	0.56	0.61
Efficiency & Turnover
Asset Turnover TTM	0.64	0.81	0.81	0.79	0.71	0.72	0.71	0.63	0.57	0.59	0.54	0.67
Days Sales Outstanding TTM	96.13	72.72	73.22	69.39	78.68	74.56	68.59	78.33	90.18	73.26	68.82	54.84
Receivables Turnover TTM	3.80	5.02	4.98	5.26	4.64	4.90	5.32	4.66	4.05	4.98	5.30	6.66
Per Share Metrics
Diluted EPS TTM	-0.29	-0.19	-0.13	-0.17	-0.15	-0.27	-0.38	-0.35	-0.48	-0.51	-0.65	-0.53
Free Cash Flow Per Share TTM	-0.15	-0.16	-0.20	-0.16	-0.16	-0.22	-0.27	-0.35	-0.40	-0.44	-0.51	-0.59
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Margin Metrics
Gross Profit Margin TTM	96.61%	71.01%	71.48%	70.15%	67.94%	68.55%	69.92%	78.75%	79.40%	76.32%	70.62%	61.60%
Operating Profit Margin TTM	-46.87%	-37.38%	-39.79%	-37.21%	-43.56%	-44.39%	-46.22%	-77.74%	-85.62%	-93.76%	-102.78%	-75.95%
Net Profit Margin TTM	-66.03%	-31.85%	-22.12%	-28.95%	-27.33%	-45.59%	-58.21%	-64.63%	-87.03%	-91.46%	-94.09%	-63.23%
Growth Metrics
Net Revenue Growth (1Y)	-23.61%	5.29%	4.12%	23.89%	20.17%	15.37%	14.51%	-19.48%	-17.39%	-13.60%	-10.39%	2.75%
Net Income Growth (1Y)	84.55%	-26.45%	-60.43%	-44.51%	-62.26%	-42.49%	-29.16%	-17.70%	-1.12%	-10.15%	-10.87%	-43.32%
EPS Growth (1Y)	83.97%	-28.81%	-65.39%	-51.85%	-67.27%	-48.45%	-41.88%	-32.93%	-19.85%	-27.90%	-13.03%	-44.30%
Valuation Metrics
P/E TTM	-1.29	-3.00	-4.85	-5.48	-8.12	-3.77	-2.39	-4.23	-1.46	-1.85	-1.69	-3.56
P/B TTM	-31.28	16.19	6.74	6.50	6.92	4.18	4.46	6.10	2.19	2.63	2.11	4.51
P/S TTM	0.85	0.95	1.07	1.58	2.22	1.72	1.39	2.74	1.27	1.69	1.59	2.25
Market Cap	23.49M	35.51M	39.77M	58.61M	80.14M	60.73M	49.54M	81.68M	38.18M	51.71M	49.57M	83.42M
Enterprise Value	34.80M	46.13M	48.66M	64.12M	82.79M	63.33M	53.77M	83.32M	36.91M	46.05M	39.00M	78.41M
Calculated Values
Free Cash Flow TTM	-9.33M	-10.28M	-12.61M	-10.07M	-10.09M	-13.36M	-14.71M	-18.81M	-21.54M	-23.87M	-22.84M	-26.40M
Net Debt	11.31M	10.62M	8.90M	5.51M	2.65M	2.60M	4.23M	1.64M	-1.27M	-5.66M	-10.57M	-5.01M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2026-06-15Purchase

Owner: Mariani, Peter J

Title: Chief Financial Officer

Shares: 100,000

Price/Share: $0.44

Value: $44,000.00

Shares Owned: 638,113

Relationship: Officer

Ownership: Direct

2026-06-15Purchase

Owner: Chan, Phillip P.

Title: Chief Executive Officer

Shares: 10,333

Price/Share: $0.43

Value: $4,443.19

Shares Owned: 1,744,432

Relationship: Director,Officer

Ownership: Direct

2024-12-13Purchase

Owner: Mariani, Peter J

Title: Chief Financial Officer

Shares: 20,000

Price/Share: $0.96

Value: $19,200.00

Shares Owned: 401,363

Relationship: Officer

Ownership: Direct

2024-12-12Purchase

Owner: Mariani, Peter J

Title: Chief Financial Officer

Shares: 20,000

Price/Share: $0.89

Value: $17,800.00

Shares Owned: 381,363

Relationship: Officer

Ownership: Direct

2023-12-13Purchase

Owner: Jones, Edward Raymond

Title: -

Shares: 7,519

Price/Share: $1.33

Value: $10,000.27

Shares Owned: 88,834

Relationship: Director

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2026-06-15	Mariani, Peter J	Officer	Chief Financial Officer	Direct	Purchase	100,000	0.44	$44,000.00	638,113	4
2026-06-15	Chan, Phillip P.	Director,Officer	Chief Executive Officer	Direct	Purchase	10,333	0.43	$4,443.19	1,744,432	4
2024-12-13	Mariani, Peter J	Officer	Chief Financial Officer	Direct	Purchase	20,000	0.96	$19,200.00	401,363	4
2024-12-12	Mariani, Peter J	Officer	Chief Financial Officer	Direct	Purchase	20,000	0.89	$17,800.00	381,363	4
2023-12-13	Jones, Edward Raymond	Director	-	Direct	Purchase	7,519	1.33	$10,000.27	88,834	4
2023-12-13	Capponi, Vincent	Officer	President & COO	Direct	Purchase	18,797	1.33	$25,000.01	584,134	4
2023-12-13	Chan, Phillip P.	Director,Officer	Chief Executive Officer	Direct	Purchase	75,188	1.33	$100,000.04	1,068,704	4
2023-12-13	Bator, Michael G.	Director	-	Direct	Purchase	37,594	1.33	$50,000.02	125,394	4
2023-12-13	Bloch, Kathleen P.	Officer	Chief Financial Officer	Direct	Purchase	37,594	1.33	$50,000.02	467,941	4
2023-12-13	Deliargyris, Efthymios	Officer	Chief Medical Officer	Direct	Purchase	22,557	1.33	$30,000.81	348,433	4
2023-12-13	Sobel, Alan D.	Director	-	Direct	Purchase	22,557	1.33	$30,000.81	101,857	4
2023-12-13	Kim, Jiny	Director	-	Direct	Purchase	7,519	1.33	$10,000.27	77,819	4
2023-08-07	Bator, Michael G.	Director	-	Direct	Purchase	2,000	3.18	$6,360.00	87,800	4
Additional insider transactions are for subscribers only. Unlock the complete Form 4 filing history Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

26.23%

Inst. Shares: 16,456,658

Shares Outstanding: 62,738,827

2025-12-31

26.67%

Inst. Shares: 16,599,972

Shares Outstanding: 62,231,771

2025-09-30

26.13%

Inst. Shares: 16,395,533

Shares Outstanding: 62,753,959

2025-06-30

26.09%

Inst. Shares: 16,331,813

Shares Outstanding: 62,608,598

2025-03-31

27.63%

Inst. Shares: 16,779,434

Shares Outstanding: 60,731,929

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	16,456,658	62,738,827	26.23%
2025-12-31	16,599,972	62,231,771	26.67%
2025-09-30	16,395,533	62,753,959	26.13%
2025-06-30	16,331,813	62,608,598	26.09%
2025-03-31	16,779,434	60,731,929	27.63%
2024-12-31	15,315,596	54,434,609	28.14%
2024-09-30	16,427,732	54,453,006	30.17%
2024-06-30	16,593,458	54,306,041	30.56%
2024-03-31	17,450,495	54,434,609	32.06%
2023-12-31	17,743,024	44,656,391	39.73%
2023-09-30	15,051,977	44,373,969	33.92%
2023-06-30	14,540,399	44,015,380	33.03%
Additional institutional holders are for subscribers only. Unlock the complete Form 13F ownership history Start 7-day free trial

Cytosorbents Corp (CTSO) — SEC Financial Statements & Analysis

Cytosorbents Corp (CTSO) is a surgical & medical instruments & apparatus company, incorporated in DE. Cytosorbents Corp trades on Nasdaq as: CTSO. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), Cytosorbents Corp reported a -23.61% year-over-year revenue growth, a Gross Profit Margin of 96.61% (TTM), a Debt-to-Equity ratio of -51.55x, a Price-to-Sales (P/S) ratio of 0.85x (TTM), a Price-to-Book (P/B) ratio of -31.28x (TTM), at a market cap of $23.49M. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y: -23.61%
Gross Profit Margin TTM: 96.61%
Debt To Equity: -51.55x
P/S TTM: 0.85x
P/B TTM: -31.28x
Market Cap: $23.49M

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is Cytosorbents Corp in?

Cytosorbents Corp (CTSO) operates in the Surgical & Medical Instruments & Apparatus industry.

What is CTSO's market cap?

Cytosorbents Corp (CTSO) has a market capitalization of $23.49M as of 2026-06-30.

What exchange does CTSO trade on?

Cytosorbents Corp (CTSO) trades on the Nasdaq.

Where is Cytosorbents Corp incorporated?

Cytosorbents Corp is incorporated in DE.